1 Min Read
Nov 13 (Reuters) - Melinta Therapeutics, Inc.-
* Melinta Therapeutics reports first patient treated in Phase 2 study of topical radezolid for treatment of acne Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.